Skip to Main Content

Paper Details

Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
Dig Dis
1
2023
GLM, Golimumab, Patients, UC, anti-TNF, fecal calprotectin, golimumab, patients, ulcerative colitis
Author NameAffiliation
Matthias SchwabInstitut fur Klinische Pharmakologie
Matthias SchwabDepartment fur Experimentelle und Klinische Pharmakologie und Pharmakogenomik, Universitat Tubingen
Stefan SchreiberChristian-Albrechts-Universitat zu Kiel
  • 1 - 3

Datasets

Release 1.2